People struggling with alcohol or drug problems in Norway now have a slimmer chance of receiving specialist care than they did a few years ago, and that chance still depends heavily on where they live. Treatment numbers have slipped year after year even though substance use disorders continue to drive illness, family hardship and early death.
A population based registry study published in Research in Health Services & Regions examined every publicly funded specialist contact for adults with substance use disorders between 2017 and 2021. Researchers identified 58,889 unique patients and calculated age and sex adjusted rates across Norway’s 21 hospital catchment areas.
The five year national rate reached 14 patients per 1,000 inhabitants, yet the annual figure fell steadily from 6.1 to 5.5 per 1,000. Coverage was more than three times higher in some districts than others. One western catchment area recorded 3.7 patients per 1,000 while an inner Oslo area reached 11.5 per 1,000.
Alcohol use disorders accounted for the largest share of both outpatient consultations and inpatient admissions, followed by opioid and cannabis related problems. Outpatient care was far more common than hospital stays, yet geographic differences were greater for outpatient services than for admissions.
Regional health authorities purchase extra capacity from private providers, especially long stay inpatient beds. That extra activity lifted overall treatment volume but left the large differences between areas almost unchanged. Variation stayed high even after the most extreme rates were set aside.
The pattern matters because only a small share of people with alcohol use disorder ever reach specialist services. Norway already records hundreds of overdose deaths each year and substance use disorders raise the risk of suicide. Falling treatment rates therefore sit uneasily beside rising need.
The authors conclude that stronger regional planning could shrink unwarranted variation. Shifting resources from lengthy inpatient stays towards more outpatient care would let the same budget reach more patients and reduce postcode lottery effects. More consistent clinical practice for specific substances would also help.
Norway’s specialist services are tax funded and patients may choose providers, yet local capacity, referral habits and procurement patterns still produce marked inequality. The decline in treatment began before the pandemic years and continued through them, suggesting the trend is structural rather than temporary.
Better matching of services to local demand would improve both fairness and overall coverage for a group that already faces high health and social costs.
